BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  St. Anthony’s Triathlon Announced as 2019 USAT Regional Championship in Both Olympic-Distance and Paratriathlon Championship

  USA Triathlon selects the 36th annual St. Anthony’s Triathlon as a 2019 regional championship race

  February 7, 2019

   · 

  2 min read
• Drug Development

  Sanofi announces additional data on avalglucosidase alfa in Pompe disease

  Results from multiple studies of the investigational therapy avalglucosidase alfa in patients with Pompe disease were presented this week during the 15th Annual WORLDSymposium™ in Orlando, Florida

  February 7, 2019

   · 

  5 min read
• Deals

  Blueprint Medicines to Present at Upcoming Investor Conferences in February

  Blueprint Medicines Corporation, a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy, announced its participation in the following upcoming investor conferences

  February 7, 2019

   · 

  1 min read
• Business

  MEI Pharma Reports Second Quarter Fiscal Year 2019 Results and Operational Highlights

  MEI Remains in Strong Position as ME-401 Advances to Global Phase 2 Study to Support FDA Accelerated Approval

  February 7, 2019

   · 

  10 min read
• Business

  Twist Bioscience Announces Appointment of Martin Kunz as Senior Vice President, Operations

  Announces Executive Promotions of Mark Daniels, Patrick Finn, Ph.D., and Patrick Weiss

  February 7, 2019

   · 

  5 min read
• Business

  Medpace Holdings, Inc. to Report Fourth Quarter and Fiscal Year 2018 Financial Results on February 25, 2019

  Medpace Holdings, Inc. announced that it will report its fourth quarter and fiscal year 2018 financial results after the market close on Monday, February 25, 2019.

  February 7, 2019

   · 

  1 min read
• Uniquely configurable Flexicon FPC60 fill/finish system offers production flexibility

  Watson-Marlow Fluid Technology Group has unveiled the new Flexicon FPC60 highly accurate peristaltic fill/finish system

  February 7, 2019

   · 

  2 min read
• Drug Development

  Sangamo Announces Interim Results Of Phase 1/2 EMPOWERS Study Evaluating SB-318 Zinc Finger Nuclease (ZFN) In Vivo Genome Editing Demonstrating Increased Leukocyte IDUA Activity In Patients With MPS I

  Sangamo Therapeutics, Inc. (NASDAQ: SGMO) today presented interim data from the Phase 1/2 EMPOWERS Study evaluating the SB-318 zinc finger nuclease (ZFN) in vivo (inside the body) genome editing product candidate in patients with Mucopolysaccharidosis Type I (MPS I).

  February 7, 2019

   · 

  8 min read
• BioMidwest

  UnitedHealthcare Confronts the Opioid Epidemic by Introducing Oral Health Programs and Policies

  UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, has introduced oral health strategies to confront the opioid epidemic, building on a companywide approach to address the epidemic from all angles

  February 7, 2019

   · 

  4 min read
• Biotech Bay

  New Study Finds Disease-Causing Variants More Common in Men with Prostate Cancer Than Previously Thought

  The largest study to date on the genetics of prostate cancer has found that 17 percent of prostate cancer patients are born with genetic variants that can be associated with higher risk of various cancers

  February 7, 2019

   · 

  5 min read